Geode Capital Management
ENZY

Geode Capital Management’s Enzymotec Ltd ENZY Stock Holding History

Geode Capital Management’s Portfolio ENZY Stock Details ENZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-10,987
Closed -$130K – 4144
2017
Q4 		$130K Hold
10,987
– – ﹤0.01% 3767
2017
Q3 		$125K Hold
10,987
– – ﹤0.01% 3780
2017
Q2 		$88K Sell
10,987
-3,396
-24% -$28.3K ﹤0.01% 3868
2017
Q1 		$126K Buy
14,383
+4,028
+39% +$34.1K ﹤0.01% 3779
2016
Q4 		$67K Buy
10,355
+172
+2% +$1.13K ﹤0.01% 3867
2016
Q3 		$71K Buy
10,183
+43
+0.4% +$345 ﹤0.01% 3875
2016
Q2 		$84K Sell
10,140
-2,500
-20% -$20.7K ﹤0.01% 3838
2016
Q1 		$114K Buy
+12,640
New +$110K ﹤0.01% 3804

Geode Capital Management's ENZY Position: Q1 2018 in Review

Geode Capital Management sold out of Enzymotec Ltd (ENZY) in Q1 2018, closing a stake of 10,987 shares — an estimated $130K sold.

Geode Capital Management first reported a position in ENZY in Q1 2016 and held it in 8 quarters. The position peaked at $130K in Q4 2017. 0 funds tracked by Wall St. Rank hold ENZY as of Q1 2018.

  • Geode Capital Management reported no remaining Enzymotec Ltd position as of Q1 2018 after selling out during the quarter.
  • Geode Capital Management sold 10,987 Enzymotec Ltd shares in Q1 2018, an estimated $130K.
  • Geode Capital Management first reported a position in Enzymotec Ltd in Q1 2016 and held it in 8 quarters.
  • Geode Capital Management's Enzymotec Ltd position peaked at $130K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held Enzymotec Ltd as of Q1 2018.

Based on Geode Capital Management's 13F filing for Q1 2018, filed 15 May 2018.